Objectives To assess changes in quality of care for children at risk for autism spectrum disorders (ASD) due to process improvement and implementation of a digital screening form.
study, experts on ASD missed 39% of children with ASD in assessments made from viewing tapes of 10-minute segments of child behavior during an ASD testing session. 5 Such errors can translate into delays in diagnosis and services. In one large study of children with ASD, mean lag time between first parental concern and diagnosis of ASD was 2.7 years, and proactive physician response to parent concerns was associated with a 1-year reduction in lag time. 6 Studies showing the impact of early treatment for children with ASD have led to agreement that innovation in early screening and referral practices is of high importance. [7] [8] [9] For universal screening for ASD to be feasible, however, process improvement is needed to make an acceptable and high-quality screening process.
Although the M-CHAT-R/F allows for early identification of children at risk for ASD who would otherwise be missed, its administration has proven challenging. The follow-up interview questions can take considerable time, and in the validation study this step was performed by research assistants rather than members of the clinical practices. 2 Secondary screening is not performed easily in the limited time available to a physician, nor do many pediatric offices have available staff to whom this important aspect of screening can be delegated. The extent to which pediatric practices in the US using the Modified Checklist for Autism in Toddlers -Revised (M-CHAT-R) actually use the follow-up questions as intended is not known. In our community, feedback from local physicians and preliminary records review suggest that many physicians skip this important step due to time constraints or insufficient awareness of the importance of the follow-up questions. Additional challenges in the screening process include mis-scoring of paper questionnaires, lack of awareness of the importance of screening, and a dearth of autism-specific resources for children who have screened positive for ASD. 7, 10 These hindrances prevent accurate estimation of the impact of screening and impede appropriate and timely care for children with ASD.
Digital screening potentially offers an answer to the logistical challenges of administering the M-CHAT-R/F. Studies seeking to improve the ASD-screening process have shown that introduction of digital smartform technology and electronic decision support can significantly impact autism-specific and general developmental screening. [10] [11] [12] [13] Therefore, we designed a quality improvement study to address the following questions: (1) Can digital smartform technology be used effectively to implement the M-CHAT-R/F secondary follow-up questions in routine care? (2) Does use of this technology increase the fidelity of implementation, accurate documentation, and appropriate action? (3) Does use of this technology increase the acceptability of ASD screening to physicians in a primary care practice? We monitored quality metrics prospectively during a baseline period and then during implementation of the intervention, as well as measures of feasibility and acceptability of the new screening process.
Methods
According to preliminary record review in 2014, 99% of children presenting for 18 and 24 months' well child visits at all Duke Children's Primary Care clinics were screened for ASD with the M-CHAT. Feedback from pediatricians and chart review, however, revealed that there was minimal use of the follow-up questions; most pediatricians were using clinical judgment to decide whether to take action on a positive screen, which can result in over-as well as under-referrals. We selected one clinic that agreed to undertake a quality improvement project and sought to quantify improvement in care. The selected clinic is staffed by approximately 20 resident and attending pediatricians who screen nearly 100 children for ASD each month. Demographic information on the children in our target population during the study period is presented in Table I . When we began planning, Duke Children's Primary Care clinics had converted to the latest version of the M-CHAT (M-CHAT-R), and the physicians were being instructed to use the follow-up interview to limit false-positive results. Many physicians did not use the follow-up questions, however, presumably because of the increased time required for implementation during routine care. Therefore, we decided to measure the impact of the intervention not only on quality metrics but also on physician-perceived feasibility and acceptability.
Planning
In September of 2014, the study team met with clinic staff to inquire about current screening practices and solicit feedback on necessary features and desired areas for improvement at the clinic. Staff requested the following process modifications: integration of follow-up questions, automatic scoring with decision support for referral action, integration of a Spanish translation, and electronic importation of results into the electronic health record (EHR). The study team immediately implemented the requested electronic decision support in physician notes to raise awareness of screening guidelines and to control for potential confounding from this facet of screening practices. All discussed features were incorporated in the intervention period except integration with the EHR, which was not possible at the time. Data on planned study measures were collected prospectively for the next 7 months, which provided a baseline period before the digital smartform intervention was implemented. We chose the quality improvement framework of Plan-DoStudy-Act (PDSA) cycles to allow us to deliver timely results to the clinic and adapt the intervention to suit the flow of the clinic. PDSA cycles involve collecting data on quality metrics at regular intervals and updating the intervention until statistical evidence of change is apparent. 14 We included children between 16 and 30 months old (the validated age range for the M-CHAT-R/F) presenting for a well child check at the clinic. Process measures (variables selected as indicators of change in screening) included accurate documentation of positive screens in the EHR and appropriate action after positive screens. Appropriate action was defined as use of the followup questions for secondary screening to rule out false-positive results, or referral of children who persistently screened positive for developmental evaluation. We monitored the proportion of children receiving ASD screening as a balance measure to alert staff to potential harm or failure of the intervention and indicate a need to halt the new process. 15 Chart review was performed by a medical student who first received training in the guidelines of the Health Insurance Portability and Accountability Act of 1996, research ethics, and quality improvement methods. We obtained exemption for the study from the Duke University School of Medicine institutional review board and approval from Duke's Primary Care Research Consortium. We sought guidance from the Information Technology Security Office at Duke to adequately protect digital records of patient data.
To evaluate the impact of process improvement on physician perception of screening, we administered an electronic, anonymous survey of physician screening behaviors and perception of screening with the M-CHAT-R before and after the study period (based on that of Morelli et al 10 ) to measures physician attitudes towards autism screening. Responses were given on a Likert scale from "strongly disagree" to "strongly agree," and responses of "agree" or "strongly agree" were collapsed into a measure of agreement. Questions that no longer made sense after transition to the digital M-CHAT were dropped from the postintervention survey or modified to emphasize that the question was asking the respondent about their experience with the digital M-CHAT-R/F.
Implementation
The digital smartform intervention was introduced in April of 2015. The digital version of the M-CHAT-R/F was a custombuilt tablet application that presented instructions and response items to parents. To protect patient data, the application required a provider's password to access the stored scores. The digital M-CHAT-R/F automatically scored answers and presented and scored follow-up questions for secondary screening of medium risk results (score of 3-7). Parents self-completed follow-up questions and were not able to see the final score. Nurses used a password to view results and a secure network to wirelessly print a score report that provided the calculated risk category as well as the text of the screen-positive questions both from the initial screen and the follow-up questions. The score report was provided to the physician before he or she entered the room to give the physician the opportunity to use screening results and screen-positive questions to guide his or her action and the clinical interview.
To avoid reductions in screening rates due to potential technology failure and to cope with simultaneous scheduling of target visits, nurses were instructed to revert to the old paper screening forms if clinic flow necessitated its use. Proportion of target visits in which nurses reverted to paper M-CHAT was collected to determine how quickly technology could be incorporated into practice and to study the amount of troubleshooting associated with adaptation of the intervention. Monthly updates on process measures were provided to the clinic, and adaptations were made to the intervention in the framework of the PDSA cycles. 15 In response to lack of change in process measures in the first month of implementation, the intervention was adapted to include individual feedback to physicians on missed positive screens after the first PDSA cycle. After this adaptation, the intervention period, which was planned for 6 months, was extended 1 month. Near the end of the final month, preliminary results were presented to the physicians and clinic managers, and the survey was readministered with additional questions about perceptions of feasibility of the digital screening process.
Statistical Analyses
Statistical process control charts were monitored for statistical evidence of change in process and balance measures by Western Electric Company (WECO) rules. In WECO rules, each point is within normal variation until one of the following criteria are met: 1 point is more than 3 SD from the mean; 2 of 3 subsequent points are more than 2 SDs from the mean; 4 of 5 subsequent points are more than 1 SD from the mean; or 8 successive points are on the same side of (above or below) the mean. 16 c 2 tests of independence and t tests were planned to compare demographics of the children studied. For the final analysis, c 2 tests of independence and the Fisher exact test were planned to compare the survey results and the process measures for the baseline and intervention periods. An alpha level of 0.05 was chosen for statistical significance. Data analysis for comparison of the baseline to the intervention period was shifted forward 1 month, to incorporate the adaptation of the intervention after the first month in response to lack of change in process measures. A secondary analysis also was performed with this month added back in to determine whether excluding this month impacted the results. All statistical analyses were carried out in R version 3.3.0 (http://www.r-project.org/, Vienna, Austria) using the packages qcc, data.table, dplyr, and psych.
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Results
The analyzed sample included 1191 children between 16 and 30 months old, with 99% of children screened. The baseline and intervention cohorts were not different statistically in age or sex distributions. For unknown reasons, the distribution of race and ethnicity differed slightly between the 2 cohorts, with 6% more African Americans in the baseline period ( Table I) . During the intervention months, a mean of 72% of children were screened with the smartform per month, with the remainder of those screened receiving paper forms. In the first month of intervention, 62% of children were screened with the digital form. During feedback sessions, nurses indicated that paper forms were used because of challenges with technology implementation in the first month and adjustment to the logistics of multiple patients requiring screening simultaneously. By the final month of the intervention, however, 80% of children were being screened with the digital form, with continued use of the paper form occurring primarily when multiple patients arrived for visits and required screening simultaneously.
Recorded scores in the EHR were confirmed by review of all digital score reports and rescoring of all available paper forms (some paper forms were not retained, mean retained 88% per month, standard deviation 8%). Forty-four children from the baseline cohort also were included in the intervention cohort (3%) due to children presenting for 18-month visits returning for 24-month visits, potentially impacting the statistical assumption of independent observation. The monthly effect of these children, however, was likely negligible and thus assumed to not impact results.
Throughout both phases of the study period, 99% of children received screening (Figure 1) . To take into account the adaptation of the intervention in May of 2015, statistical analyses of the intervention were performed during the 6 months of May-October of 2015. To determine the impact of this decision, secondary analysis was performed with results from April added back in, and changes in process measures remained statistically significant. Because of adequate stability in the balance measure (proportion of children screened) over the course of intervention, the study was not halted at any point. During the baseline months, balance and process measures remained in statistical control (Figure 2 ; available at www.jpeds.com).
Process Measures
During the intervention period, monthly tests of change demonstrated statistically significant changes in both process measures beginning in the second month of intervention (Figure 2) . The first process measure, the proportion of children screening positive with accurate documentation in the EHR, increased from a mean of 54% to 92% (38% increase, 95% CI 14%-64%). By WECO rules, this change in documentation of Appropriate action refers to use of the follow-up questions or immediate referral for evaluation. *P < .005, †P < .001.
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positive screens was statistically significant (4 of 5 points more than 1 SD above the baseline mean) (Figure 2, A) . On the second process measure, proportion of children with appropriate action, the metric increased by 60% in the intervention period (95% CI 35%-85%). By WECO rules, statistical change was significant and maintained (2 of 3 points more than 2 SDs above the baseline mean) (Figure 2, B) . In the intervention period, of the 22 children with appropriate action, 17 were presumed false positives ruled out with use of automated secondary screening and 5 children scored high risk or remained positive after automated secondary screening and were referred for evaluation (Figure 1) . This amounted to an overall positive rate of 1.9% (5 previously identified + 5 newly identified of 529 children studied) in the intervention period.
Survey
On the preintervention survey, 16 of 20 physicians responded, and 5 had greater than 10 years of experience practicing pediatrics. On the postintervention survey, 10 of 15 surveyed physicians responded, and 5 reported greater than 10 years of experience, suggesting that a similar proportion of attending and resident physicians completed each survey. New interns were excluded from the postintervention survey because respondents were asked to compare their experiences before and after the intervention, resulting in fewer potential respondents postintervention. Before the intervention, 56% of respondents stated that they routinely referred children for developmental evaluation after a positive screen, and only 25% stated that they used the follow-up questions. After the intervention, 100% of respondents stated that they routinely referred children for developmental evaluation after a positive screen, 90% agreed that the digital version of the M-CHAT and score report improved their assessment of ASD risk, and 90% agreed that they preferred the digital method of screening over paper forms.
Respondents stated (60%) that they had tried to use the paper follow-up questions before the introduction of the digital M-CHAT. Physicians commented that the limiting factor for use of the secondary screen was time of administration. No significant changed was observed in respondent's perception of alterations in clinical flow due to screening (Table II) . Respondents commented that the automatically generated score report made use of the M-CHAT easier and faster. More attendings than residents stated that they had tried previously to use the follow-up questions; otherwise, feedback did not differ by level of experience.
Discussion
This quality improvement study demonstrated significant gains in complete and accurate use of the M-CHAT-R/F and positive changes in physician attitudes toward autism screening. Our intervention process integrated secondary screening into routine care, which in previous studies has been shown to improve the accuracy of risk assessment for ASD. Importantly, a gap in documentation of positive screens during the baseline period appeared to be due to scoring errors on paper forms and paper forms that were never scored, highlighting the need for an automated scoring system that presents risk assessment results to physicians in a busy primary care clinic. Use of the digital format steadily increased over the course of the intervention, and adaptation to new technology likely contributed to the 1-month delay in change in quality metrics. Overall, physicians found the digital format and automatic scoring helped them assess risk for ASD and incorporate that information into their referral decision. As a result of this study, the practice leadership decided to continue using the processes introduced in this intervention after the study period.
Several other elements of our intervention could be applied to expansion or adaptation of this approach. Individual feedback and the use of risk categories presented to physicians in a practical and timely manner were likely key factors in our success. Results of the survey indicated that physicians found having the M-CHAT-R/F already scored and interpreted convenient and useful. Physicians also used the follow-up question more often after the intervention, as was evident in occasional explicit references to follow-up questions in their progress notes even when using the paper screening form. Uptake of digital screening could be improved with systemwide implementation of digital screening and integration with the EHR, which we hope to achieve with other planned improvements to our health system. Physicians' survey responses mirrored quantitative results, suggesting that they also judged accurately their improvement in screening practices. The question of maintaining high sensitivity while reducing false-positive results on the M-CHAT-R/F remains challenging but may be aided by digital screening. In our intervention, 65% of initial positives were ruled out as potential false positives by electronic administration of the followup questions (17 of the 26 newly identified positives), which is comparable with the 67%-78% reported in the literature (1023 of 1295 in Chlebowski et al 3 and 152 of 227 in Brooks et al 3, 22 ). Our overall positive rate was 1.9% (previously identified and newly identified positives), which also fits with previous studies showing that prevalence of ASD is about 1% and about one-half of all positive screens are children with some other kind of developmental delay. 2 The quality improvement framework potentially detected patients screening positive who would not have been included in previous studies requiring consent and opting in, because parents who are not concerned about their child's development or afraid of the implications of an ASD diagnosis may decline study participation.
An ethical consideration for digital screening is that parents might answer follow-up questions differently when presented with questions electronically than when interviewed. It is our experience that parents sometimes do not understand the underlying behavior described in the questions or intentionally give the screen-negative answer because they are not ready to hear that their child may be at risk for ASD. Therefore, it is vital that physicians engage with parents over their responses to the questions and continue close follow-up for families where either the physician or parent is concerned. Physicians in our study reported that because the score report displayed screen-positive questions, they could discuss the questions with parents. Although discussing screening results may add time to a well child visit, with the improved specificity of screening conferred with the digital form, we observed an overall decrease in the number of positive screens, potentially reducing the number of visits in which physicians need to discuss screening results. In North Carolina and many other states, both private insurance and Medicaid reimburse physicians for every administered M-CHAT, and implied here is reimbursement for the time taken to review results. Further adaption of digital screening could increase confidence in the specificity of the screen, allowing physicians to allocate time-consuming discussions of positive screening results to the families of children at greatest risk for ASD.
The generalizability of these results beyond the intervention site is limited by the lack of a contemporaneous comparison site and potential cointerventions. We chose not to use a comparison site for this study and instead planned a prospective baseline vs postintervention analysis. In an effort to control for the impact of increased awareness on quality of screening, however, we introduced decision support elements in the EHR and promoted the importance of screening during the baseline period. We were surprised to find no significant change in outcome measures during baseline, suggesting that discussion of the screening guidelines and familiarity with the research goals had little impact on the changes that occurred during the intervention period, possibly because of the logistical challenges of administering the follow-up questions. Similarly, sources of potential cointervention, such as the Center for Disease Control and Prevention's "Learn the Signs. Act Early" campaign, North Carolina's Assuring Better Child Health and Development initiative, and studies recruiting children with ASD were ongoing throughout the baseline and intervention periods. We suspect these had little impact on the intervention effect, although we cannot rule out their interaction with our intervention.
We also recognize the limitations afforded by lack of diagnostic outcomes results. We did not follow these patients to diagnostic result and clinical outcome, which is an important gap in the screening literature. Studies that attempt to quantify the impact of screening, however, have limited interpretability because of the low use of the full M-CHAT-R/F (with follow-up questions). 23 Given the evidence in this study of the logistical challenges inherent in implementing the M-CHAT-R/F in primary care practice, it is crucial that sustainable and scalable process improvement be undertaken before passing judgment on the impact of screening for ASD. Studies of both feasibility of screening processes and long-term outcomes of children who receive early screening will be necessary to fully understand the impact of early screening. 24 Future studies should quantify the impact of early screening on age of diagnosis for ASD and other developmental delays and time to treatment initiation to further elucidate the impact of universal early screening on progress in clinical care.
We found a measurable impact of this intervention on number of positive screens, fidelity of documentation, and clinical action. We monitored the impact of changes in the screening process on early referral, which is an important step for many children toward early treatment, a proxy for improved outcomes in ASD. Use of the M-CHAT-R with follow-up questions to reduce potential false positives improves the potential harm to benefit ratio of screening and allows physicians to have more confidence in screening results. With expanding demands and short visit times, interventions that reduce time spent scoring and interpreting forms could preserve time for direct patient care. This study demonstrates the potential for technology to assist in improving feasibility and acceptability of universal screening for ASD. ■ 
